National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 50461-50462 [2019-20753]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 186 / Wednesday, September 25, 2019 / Notices
Healthcare Professionals in Academia
and Clinical Research, Office of Clinical
Research (OCR), National Institutes of
Health (NIH), Office of the Director
(OD).
Need and Use of Information
Collection: The purpose of this survey is
to assess the long-term impact and
outcomes of clinical research training
programs provided by the Office of
Clinical Research located in the NIH
Office of the Director (OD) over a tenyear follow-up period. The information
received from respondents will provide
insight on the following: Impact of the
courses on (a) promotion of professional
competence, (b) research productivity
and independence, and (c) future career
development within clinical,
The Office of Clinical Research, Office
of the Director, National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Application and
Impact of Clinical Research Training on
50461
translational and academic research
settings. These surveys will provide
preliminary data and guidance in (1)
developing recommendations for
collecting outcomes to assess the
effectiveness of the training courses, and
(2) tracking the impact of the
curriculum on participants’ ability to
perform successfully in academic, nonacademic, research, and non-research
settings.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,589.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Average time
per response
(in hours)
Total annual
burden hours
Type of respondents
OCR Learning Portal Registration (Attachment 1)
2000
1
10/60
333
1000
500
750
1
1
1
10/60
10/60
10/60
167
83
125
500
250
750
1
1
1
10/60
10/60
10/60
83
42
125
500
250
750
1
1
1
10/60
10/60
10/60
83
42
125
500
250
750
1
1
1
10/60
10/60
10/60
83
42
125
NIH Summer Course in Clinical and Translational
Research Course Evaluation (Attachment 6).
Sabbatical in Clinical Research Management
Course Evaluation (Attachment 7).
Healthcare Professionals.
Students .......................
General Public ..............
Healthcare Professionals.
Students .......................
General Public ..............
Healthcare Professionals.
Students .......................
General Public ..............
Healthcare Professionals.
Students .......................
General Public ..............
Healthcare Professionals.
Students .......................
General Public ..............
Healthcare Professionals.
Healthcare Professionals.
500
250
20
1
1
1
10/60
10/60
10/60
83
42
3
20
1
10/60
3
Total ...............................................................
.......................................
........................
9,540
........................
1,589
IPPCR Lecture Evaluation (Attachment 2) ...........
IPPCR Final Course Evaluation (Attachment 4) ..
PCP Lecture Evaluation (Attachment 3) ..............
PCP Final Course Evaluation (Attachment 5) ......
Dated: September 18, 2019.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–20747 Filed 9–24–19; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
BILLING CODE 4140–01–P
jbell on DSK3GLQ082PROD with NOTICES
Estimated
number of
respondents
Form name
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
18:25 Sep 24, 2019
Jkt 247001
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group Single-Site and
Pilot Clinical Trials Review Committee
NHLBI Single-Site Clinical Trials & Pilot
Studies.
Date: October 30–31, 2019.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\25SEN1.SGM
25SEN1
50462
Federal Register / Vol. 84, No. 186 / Wednesday, September 25, 2019 / Notices
Place: Embassy Suites—Chevy Chase
Pavilion, Tenley Town Ballroom, 4300
Military Road NW, Washington, DC 20015.
Contact Person: Carol (Chang-Sook) Kim,
Ph.D., Scientific Review Administrator,
Office of Scientific Review/DERA, National
Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7188, Bethesda, MD
20892, 301–827–7940, carolko@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20753 Filed 9–24–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
jbell on DSK3GLQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research.
Date: October 24–25, 2019.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892, 301–
827–7992, stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
VerDate Sep<11>2014
18:25 Sep 24, 2019
Jkt 247001
Dated: September 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20757 Filed 9–24–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIA.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual grant
applications conducted by the
NATIONAL INSTITUTE ON AGING,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIA.
Date: October 13–15, 2020.
Closed: October 13, 2020, 8:00 a.m. to 8:20
a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Open: October 13, 2020, 8:20 a.m. to 11:50
a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Closed: October 13, 2020, 11:50 a.m. to
1:05 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Open: October 13, 2020, 1:05 p.m. to 4:05
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Closed: October 13, 2020, 4:05 p.m. to 5:45
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Closed: October 14, 2020, 8:00 a.m. to 8:20
a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Open: October 14, 2020, 8:20 a.m. to 11:50
a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Closed: October 14, 2020, 11:50 a.m. to
1:05 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Open: October 14, 2020, 1:05 p.m. to 3:05
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Closed: October 14, 2020, 3:05 p.m. to 3:55
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Open: October 14, 2020, 3:55 p.m. to 4:55
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224.
Closed: October 14, 2020, 4:55 p.m. to 5:55
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 84, Number 186 (Wednesday, September 25, 2019)]
[Notices]
[Pages 50461-50462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Heart, Lung, and Blood Initial Review Group
Single-Site and Pilot Clinical Trials Review Committee NHLBI Single-
Site Clinical Trials & Pilot Studies.
Date: October 30-31, 2019.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 50462]]
Place: Embassy Suites--Chevy Chase Pavilion, Tenley Town
Ballroom, 4300 Military Road NW, Washington, DC 20015.
Contact Person: Carol (Chang-Sook) Kim, Ph.D., Scientific Review
Administrator, Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge Drive, Room 7188,
Bethesda, MD 20892, 301-827-7940, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-20753 Filed 9-24-19; 8:45 am]
BILLING CODE 4140-01-P
